Selumetinib, Advanced Uveal Melanoma Drug, Shows Success In Clinical Trial
Category: WELLNESS
The team wants to combine Mekinist with an experimental Glaxo treatment that blocks a different protein called Akt based
By Reuters, Reuters, 2013-06-01